The protective function of galectin-9 in liver ischemia and reperfusion injury in mice

Liver Transplantation

Volumn 21, Issue 7, 2015, Pages 969-981

  Hirao, Hirofumi ^a,b   Uchida, Yoichiro ^a,b   Kadono, Kentaro ^a,b   Tanaka, Hirokazu ^a   Niki, Toshiro ^c,d   Yamauchi, Akira ^b   Hata, Koichiro ^a   Watanabe, Takeshi ^b   Terajima, Hiroaki ^b   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d Research Division GalPharma Company Ltd NEXT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; ECALECTIN; TOLL LIKE RECEPTOR 4; GALECTIN; GALECTIN 9, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; HOMEOSTASIS; INFLAMMATORY CELL; KUPFFER CELL; LIVER; LIVER CELL; LIVER CELL DAMAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; T LYMPHOCYTE; UPREGULATION; ANIMAL; APOPTOSIS; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISCHEMIA; KNOCKOUT MOUSE; LIVER DISEASE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALECTINS; HEPATOCYTES; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISCHEMIA; KUPFFER CELLS; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84933507160     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24159     Document Type: Article

References (39)

1. Kishore U, Eggleton P, Reid KB,. Modular organization of carbohydrate recognition domains in animal lectins. Matrix Biol 1997; 15: 583-592.
2. Rabinovich GA, Toscano MA,. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 2009; 9: 338-352.
3. van Kooyk Y, Rabinovich GA,. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol 2008; 9: 593-601.
4. Wada J, Kanwar YS,. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem 1997; 272: 6078-6086.
5. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS,. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 1997; 99: 2452-2461.
6. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, et al., Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998; 273: 16,976-16,984.
7. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6: 1245-1252.
8. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K, et al., Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008; 127: 78-88.
9. Lv K, Xu W, Wang C, Niki T, Hirashima M, Xiong S,. Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells. Clin Immunol 2011; 140: 92-101.
10. Kadowaki T, Morishita A, Niki T, Hara J, Sato M, Tani J, et al., Galectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages. Crit Care 2013; 17: R284.
11. Chou FC, Shieh SJ, Sytwu HK,. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 2009; 39: 2403-2411.
12. Kanzaki M, Wada J, Sugiyama K, Nakatsuka A, Teshigawara S, Murakami K, et al., Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Endocrinology 2012; 153: 612-620.
13. Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, et al., A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One 2010; 5: e9504.
14. Lv K, Zhang Y, Zhang M, Zhong M, Suo Q,. Galectin-9 ameliorates Con A-induced hepatitis by inducing CD4(+)CD25(low/int) effector T-cell apoptosis and increasing regulatory T cell number. PLoS One 2012; 7: e48379.
15. Farmer DG, Amersi F, Kupiec-Weglinski J, Busuttil RW,. Current status of ischemia and reperfusion injury in the liver. Transplant Rev 2000; 14: 106-126.
16. Teoh NC, Farrell GC,. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
17. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ,. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 1991; 15: 277-284.
18. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN,. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253 (part 2): H699-H703.
19. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF,. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279-289.
20. Shen X, Wang Y, Gao F, Ren F, Busuttil RW, Kupiec-Weglinski JW, Zhai Y,. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009; 50: 1537-1546.
21. Hanschen M, Zahler S, Krombach F, Khandoga A,. Reciprocal activation between CD4+ T cells and Kupffer cells during hepatic ischemia-reperfusion. Transplantation 2008; 86: 710-718.
22. Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, et al., T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004; 172: 7169-7176.
23. Wang F, He W, Yuan J, Wu K, Zhou H, Zhang W, Chen ZK,. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transpl Immunol 2008; 19: 12-19.
24. Uchida Y, Ke B, Freitas MC, Ji H, Zhao D, Benjamin ER, et al., The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse. Hepatology 2010; 51: 1363-1372.
25. Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, et al., T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139: 2195-2206.
26. Uchida Y, Freitas MC, Zhao D, Busuttil RW, Kupiec-Weglinski JW,. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl 2009; 15: 939-947.
27. Nishi N, Itoh A, Fujiyama A, Yoshida N, Araya S, Hirashima M, et al., Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett 2005; 579: 2058-2064.
28. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D,. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265-1272.
29. Seki M, Sakata KM, Oomizu S, Arikawa T, Sakata A, Ueno M, et al., Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 2007; 56: 3968-3976.
30. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ,. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 1998; 27: 1172-1177.
31. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, et al., Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005; 175: 7661-7668.
32. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr,. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-1943.
33. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ,. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173.
34. Uchida Y, Freitas MC, Zhao D, Busuttil RW, Kupiec-Weglinski JW,. The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury. Transplantation 2010; 89: 1050-1056.
35. Rüdiger HA, Graf R, Clavien PA,. Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003; 16: 149-159.
36. Liu Y, Ji H, Zhang Y, Shen X, Gao F, He X, et al., Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury. J Hepatol 2015; 62: 563-572.
37. Gooden MJ, Wiersma VR, Samplonius DF, Gerssen J, van Ginkel RJ, Nijman HW, et al., Galectin-9 activates and expands human T-helper 1 cells. PLoS One 2013; 8: e65616.
38. Zhai Y, Shen XD, O'Connell R, Gao F, Lassman C, Busuttil RW, et al., Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 7115-7119.
39. Nace GW, Huang H, Klune JR, Eid RE, Rosborough BR, Korff S, et al., Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice. Hepatology 2013; 58: 374-387.